Aguilar Laura K.

CIK 00018739151 companyWABAN, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001873915

Recent Transactions

50 trades

Disposition to Issuer
Candel Therapeutics, Inc.$CADL
CADL
2025-02-21$12.02/sh−10,582→ 120,861 total
Disposition to Issuer
Candel Therapeutics, Inc.$CADL
CADL
2025-02-21$12.02/sh−10,583→ 162,929 total
Disposition to Issuer
Candel Therapeutics, Inc.$CADL
CADL
2025-02-10$8.61/sh−31,335→ 60,000 total
Disposition to Issuer
Candel Therapeutics, Inc.$CADL
CADL
2024-12-27$8.85/sh−50,000→ 173,512 total
Disposition to Issuer
Candel Therapeutics, Inc.$CADL
CADL
2024-12-27$8.85/sh−50,000→ 131,443 total
Disposition to Issuer
Candel Therapeutics, Inc.$CADL
CADL
2024-12-26$9.01/sh−50,000→ 223,512 total
Disposition to Issuer
Candel Therapeutics, Inc.$CADL
CADL
2024-12-26$9.01/sh−50,000→ 181,443 total
Disposition to Issuer
Candel Therapeutics, Inc.$CADL
CADL
2024-12-24$8.82/sh+50,000→ 273,512 total
Disposition to Issuer
Candel Therapeutics, Inc.$CADL
CADL
2024-12-24$8.82/sh−50,000→ 231,443 total
Disposition to Issuer
Candel Therapeutics, Inc.$CADL
CADL
2024-12-23$8.52/sh−50,000→ 323,512 total
Disposition to Issuer
Candel Therapeutics, Inc.$CADL
CADL
2024-12-23$8.52/sh−50,000→ 281,443 total
Disposition to Issuer
Candel Therapeutics, Inc.$CADL
CADL
2024-12-20$9.00/sh−100,000→ 373,512 total
Disposition to Issuer
Candel Therapeutics, Inc.$CADL
CADL
2024-12-20$9.00/sh−100,000→ 331,443 total
Disposition to Issuer
Candel Therapeutics, Inc.$CADL
CADL
2024-12-12$10.04/sh−200,000→ 431,443 total
Disposition to Issuer
Candel Therapeutics, Inc.$CADL
CADL
2024-12-12$10.04/sh−200,000→ 473,512 total
Disposition to Issuer
Candel Therapeutics, Inc.$CADL
CADL
2024-12-11$8.53/sh−200,000→ 631,443 total
Disposition to Issuer
Candel Therapeutics, Inc.$CADL
CADL
2024-12-11$8.53/sh−200,000→ 673,512 total
Disposition to Issuer
Candel Therapeutics, Inc.$CADL
CADL
2024-12-06$5.23/sh−20,000→ 91,335 total
Disposition to Issuer
Candel Therapeutics, Inc.$CADL
CADL
2024-12-05$4.79/sh−20,000→ 111,335 total
Disposition to Issuer
Candel Therapeutics, Inc.$CADL
CADL
2024-12-04$4.46/sh−20,000→ 131,335 total
Disposition to Issuer
Candel Therapeutics, Inc.$CADL
CADL
2024-11-25$4.97/sh−20,000→ 151,335 total
Disposition to Issuer
Candel Therapeutics, Inc.$CADL
CADL
2024-11-08$4.92/sh−7,500→ 873,512 total
Disposition to Issuer
Candel Therapeutics, Inc.$CADL
CADL
2024-11-08$4.92/sh−7,500→ 831,443 total
Disposition to Issuer
Candel Therapeutics, Inc.$CADL
CADL
2024-11-07$5.19/sh−7,500→ 881,012 total
Disposition to Issuer
Candel Therapeutics, Inc.$CADL
CADL
2024-11-07$5.19/sh−7,500→ 838,943 total
Disposition to Issuer
Candel Therapeutics, Inc.$CADL
CADL
2024-11-06$5.33/sh−7,500→ 846,443 total
Disposition to Issuer
Candel Therapeutics, Inc.$CADL
CADL
2024-11-06$5.33/sh−7,500→ 888,512 total
Disposition to Issuer
Candel Therapeutics, Inc.$CADL
CADL
2024-11-01$5.27/sh−7,500→ 853,943 total
Disposition to Issuer
Candel Therapeutics, Inc.$CADL
CADL
2024-11-01$5.27/sh−7,500→ 896,012 total
Disposition to Issuer
Candel Therapeutics, Inc.$CADL
CADL
2024-10-31$5.30/sh−7,500→ 903,512 total
Disposition to Issuer
Candel Therapeutics, Inc.$CADL
CADL
2024-10-31$5.30/sh−7,500→ 861,443 total
Disposition to Issuer
Candel Therapeutics, Inc.$CADL
CADL
2024-10-30$5.38/sh−6,000→ 868,943 total
Disposition to Issuer
Candel Therapeutics, Inc.$CADL
CADL
2024-10-30$5.38/sh−6,000→ 911,012 total
Disposition to Issuer
Candel Therapeutics, Inc.$CADL
CADL
2024-10-28$5.58/sh−11,711→ 888,532 total
Disposition to Issuer
Candel Therapeutics, Inc.$CADL
CADL
2024-10-25$5.80/sh−1,597→ 900,243 total
Disposition to Issuer
Candel Therapeutics, Inc.$CADL
CADL
2024-10-24$5.53/sh−16,427→ 903,034 total
Disposition to Issuer
Candel Therapeutics, Inc.$CADL
CADL
2024-10-24$5.72/sh−1,194→ 901,840 total
Sale
Candel Therapeutics, Inc.$CADL
CADL
2024-10-15$6.03/sh−10,412→ 919,461 total
Sale
Candel Therapeutics, Inc.$CADL
CADL
2024-10-14$6.02/sh−15,000→ 929,873 total
Sale
Candel Therapeutics, Inc.$CADL
CADL
2024-10-11$6.05/sh−15,000→ 944,873 total
Sale
Candel Therapeutics, Inc.$CADL
CADL
2024-10-03$6.85/sh−1,800→ 959,873 total
Sale
Candel Therapeutics, Inc.$CADL
CADL
2024-10-02$6.92/sh−26,988→ 961,673 total
Sale
Candel Therapeutics, Inc.$CADL
CADL
2024-10-01$7.01/sh+6,214→ 988,661 total
Exercise/Conversion
Candel Therapeutics, Inc.$CADL
Stock Option (Right to Buy)
2022-05-06−76,717→ 0 total
Exercise/Conversion
Candel Therapeutics, Inc.$CADL
Stock Option (Right to Buy)
2022-05-06−76,717→ 0 total
Tax Payment
Candel Therapeutics, Inc.$CADL
Common Stock
2022-05-06$3.65/sh−68,534→ 1,033,840 total
Exercise/Conversion
Candel Therapeutics, Inc.$CADL
Common Stock
2022-05-06$1.46/sh+171,335→ 1,102,374 total
Exercise/Conversion
Candel Therapeutics, Inc.$CADL
Stock Option (Right to Buy)
2022-05-06−17,901→ 0 total
Conversion
Candel Therapeutics, Inc.$CADL
Common Stock
2021-07-29+56,096→ 931,039 total
Conversion
Candel Therapeutics, Inc.$CADL
Series B Preferred Stock
2021-07-29−137,881→ 0 total

Companies

Candel Therapeutics, Inc.
10% Owner
$CADL

Recent Filings

Address

160 PAULSON RD.

WABAN, MA, 02468

View on SEC.gov